Raymond W Cohen bought $200k of KMTS
director at KESTRA MEDICAL TECHNOLOGIES, LTD.. 10,000 shares at an average of $19.98, traded Mar 26, 2026, filed Mar 30, 2026.
Score components
- +15RoleDirector
- +12Trade size$200k at market
- +6Relative to holdingsHoldings up 24%
- +4Price context30% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +6.4%, 3m +38.3%, 6m +53.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-132324, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | POpen-market purchase Common Shares | +10,000 | $19.98 | $200k | 50,903 | Mar 30, 2026 |
Related signals
Other insiders at KESTRA MEDICAL TECHNOLOGIES, LTD. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | KESTRA MEDICAL TECHNOLOGIES, LTD. | Raymond W Cohen director | $98k 3,330 shares | -6% | |
| 45Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Elizabeth Kwo director | $97k 4,010 shares | -22% | |
| 51Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Conor Hanley director | $144k 5,694 shares | -48% | |
| 50Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Jeffrey Lawrence Schwartz director, owner | $98k 3,890 shares | -36% | |
| 40Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Mary Kay Ladone director | $98k 3,908 shares | -9% | |
| 48Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Kevin C Reilly director | $74k 2,932 shares | -35% | |
| 26Weak | KESTRA MEDICAL TECHNOLOGIES, LTD. | Brian Daniel Webster See Remarks | $412k 15,000 shares | -3% | |
| 48Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Vaseem Mahboob Chief Financial Officer | $680k 26,287 shares | -30% | |
| 41Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Alfred J Ford Jr Chief Commercial Officer | $151k 6,275 shares | -6% | |
| 55Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Brian Daniel Webster See Remarks | $1.3M 51,900 shares | -10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.